Shin Nippon Biomedical Laboratories Ltd 2395
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥1,497.00
- Day Range
- ¥1,400.00–1,490.00
- 52-Week Range
- ¥1,067.00–2,005.00
- Bid/Ask
- ¥1,418.00 / ¥1,420.00
- Shares Outstanding
- 41.63M
- Market Cap
- ¥59.08B
- Volume/Avg
- 561,400 / 227,856
Key Statistics
- Price/Earnings (Normalized)
- 11.28
- Price/Sales
- 1.84
- Dividend Yield (Trailing)
- 3.34%
- Dividend Yield (Forward)
- 3.34%
- Dividend Payment Schedule
- Jun, Nov
- Total Yield
- 3.34%
Company Profile
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company's segment includes: CRO business (non-clinical business and clinical business), translational research business, Medipolis business, U.S. real estate business, and other businesses. The CRO business segment derives maximum revenue.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 994
- Website
- http://www.snbl.co.jp
Valuation
|
Metric
|
2395
|
|---|---|
Price/Earnings (Normalized) | 11.28 |
Price/Book Value | 1.49 |
Price/Sales | 1.84 |
Price/Cash Flow | 8.25 |
Price/Earnings
2395
Financial Strength
|
Metric
|
2395
|
|---|---|
Quick Ratio | 0.54 |
Current Ratio | 1.02 |
Interest Coverage | 21.68 |
Quick Ratio
2395
Profitability
|
Metric
|
2395
|
|---|---|
Return on Assets (Normalized) | 6.77% |
Return on Equity (Normalized) | 15.99% |
Return on Invested Capital (Normalized) | 8.36% |
Return on Assets
2395
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|$M?&q@S | LOCK|&N | $249B | |||
| Danaher Corp
DHR
| LOCK|jrGLk&Q> | LOCK|T$ | $158B | |||
| Agilent Technologies Inc
A
| LOCK|%%<j>!xG | LOCK|d#? | $49B | |||
| IQVIA Holdings Inc
IQV
| LOCK|qM%>n&@ | LOCK|P<Wl | $43B | |||
| Waters Corp
WAT
| LOCK|$Wd?>& | LOCK|c$z | $43B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|^<wHR%<s | LOCK|Z& | $42B | |||
| Illumina Inc
ILMN
| LOCK|>hX@<#M | LOCK|xKn@R | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|%f$S>#^ | LOCK|G@<> | $32B | |||
| Quest Diagnostics Inc
DGX
| LOCK|>z&@G! | LOCK|S<%l | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|#!H%P?& | LOCK|l#f@S | $26B |
United States